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ABSTRACT
Primate-specific NBL2 macrosatellite is hypomethy-
lated in several types of tumors, yet the conse-
quences of this DNA hypomethylation remain un-
known. We show that NBL2 conserved repeats are
close to the centromeres of most acrocentric chro-
mosomes. NBL2 associates with the perinucleolar
region and undergoes severe demethylation in a
subset of colorectal cancer (CRC). Upon DNA hy-
pomethylation and histone acetylation, NBL2 repeats
are transcribed in tumor cell lines and primary CRCs.
NBL2 monomers exhibit promoter activity, and are
contained within novel, non-polyA antisense lncR-
NAs, which we designated TNBL (Tumor-associated
NBL2 transcript). TNBL is stable throughout the mi-
totic cycle, and in interphase nuclei preferentially
forms a perinucleolar aggregate in the proximity of
a subset of NBL2 loci. TNBL aggregates interact with
the SAM68 perinucleolar body in a mirror-image can-
cer specific perinucleolar structure. TNBL binds with
high affinity to several proteins involved in nuclear
functions and RNA metabolism, such as CELF1 and
NPM1. Our data unveil novel DNA and RNA structural
features of a non-coding macrosatellite frequently al-
tered in cancer.
INTRODUCTION
Somatic global genomic hypomethylation is frequent in al-
most all cancer types (1–5). Most of the tumor-associated
somatic hypomethylation reflects demethylation of tandem
and interspersed repetitive DNA elements (6–13). Although
repetitive sequences account for at least half of the human
genome, they were long considered ‘junk’ DNA, with no
functionality (14). However, growing evidence suggests they
play diverse regulatory roles and are critical for 3D nuclear
organization (15). A causal link between DNA hypomethy-
lation and tumorigenesis, in part by promoting DNA re-
arrangements, has been described in cancers, cell lines and
mouse models (12,16–23). How demethylation of DNA re-
peats contributes to chromosomal instability and cancer
is not well understood, but several hypotheses have been
proposed. For instance, as many chromatin regulators bind
to repeat-rich pericentromeric and centromeric heterochro-
matin (24–28), cancer-associated hypomethylation is likely
to affect their binding dynamics and thus their local and
genome-wide functions (5). Also, recent reports show that
hypomethylation of satellite DNA repeats may lead to their
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aberrant transcription in several cancers (29,30), but the ef-
fects of these transcripts are mostly unknown.
Satellite DNA is characterized by tandem repeats clas-
sified into micro-, mini- and macro-satellites depending on
their repeat unit size. While micro- and mini- satellite repeat
units range from a few to 10 bp and from 10 to hundreds of
bp respectively, macrosatellite units can be of several kb. All
satellite sequences cover ∼3% of the human genome (31),
and macrosatellite repeats (MSRs) occupy strategic loca-
tions, such as telomeres, pericentromeric regions, or adja-
cent to protein coding genes. Thus, among repeat classes,
MSRs can be regarded as unique regulatory DNA struc-
tures. In somatic cells the majority of MSRs are organized
into heterochromatin.
Some MSRs were shown to play fundamental roles in
the organization of the genome and development of dis-
eases (32). In particular, reduced copy number of polycomb-
bound D4Z4 macrosatellite repeats is directly linked to the
development of facioscapulohumeral dystrophy (FSHD)
(33,34). Lower amounts of polycomb repressive complex
and consequently heterochromatin loosening, allow tran-
scription of a lncRNA, DBE-T, from D4Z4 repeats. In turn,
DBE-T recruits Ash1L in cis, resulting in aberrant upregu-
lation of adjacent genes (35). Thus, lncRNA DBE-T acts as
a mediator of the epigenetic switch occurring at the D4Z4
locus upon contraction of the repeat array.
Aside from D4Z4, the X-linked DXZ4 MSR has also
been studied in detail. DXZ4 plays a critical role in X chro-
mosome inactivation and produces long non-coding tran-
scripts, which seem to be developmentally regulated and
may contribute to heterochromatin formation at DXZ4
(36). However, other known MSRs are vaguely explored.
Many are poorly annotated, sequenced, and assembled in
the reference genome (32). Little to nothing is known about
the transcriptional deregulation of MSRs in cancer.
In our previous studies we proposed a ‘wear and tear
model’ hypothesizing that DNA hypomethylation accumu-
lates during aging by the unavoidable loss of methylation
copy fidelity during successive DNA replication rounds
(37). We also described a pericentromeric repeat element
hypomethylated in colorectal, ovarian, and breast cancers
(37,38). The repeat, initially characterized as SST1 element,
was later identified as identical to NBL2, a 1.4 kb, primate-
specific MSR discovered more than 20 years ago due to its
cancer-specific hypomethylation (39–42). Recently, we ob-
served that ‘severe’ NBL2 demethylation in 7% of colorectal
cancers (CRC) did not follow the ‘wear and tear model’ be-
cause it did not increase with the age of the cancer patients.
Further analysis associated NBL2 demethylation with ge-
nomic damage, but also with the presence of p53 mutations
in a subset of CRC (38). Our results also showed that heli-
case HELLS (also known as PASG, LSH and SMARCA6)
contributes to maintain SST1/NBL2 sequences methylated.
In continuation of this previous work, we have deter-
mined here the location of NBL2 MSR in the linear genome
and three-dimensional nuclear space. We report that NBL2
is transcribed into lncRNAs, referred as TNBL (Tumor-
associated NBL2 transcript), in CRC and provide structural
insights of this novel macrosatellite repeat-derived lncRNA.
MATERIALS AND METHODS
NBL2 in silico genomic analysis
NBL2 distribution analysis was performed by aligning
NBL2 consensus sequence (made by aligning 21 monomers
from chromosome 21) to the human genome version 38
(hg38) using the Exonerate software program (43). Each
aligned region was confirmed to belong to an SST1 region
using the “rmsk” table from the UCSC Genome Browser.
Ideograms were generated using the online visualization
tool PhenoGram (44).
Mammalian cell culture
Colorectal, ovarian and breast cancer cell lines were ob-
tained from ATCC and cultured according to recom-
mended protocols. Human-rodent somatic cell hybrid cell
lines were purchased from Coriell Institute and cultured
according to recommended culturing conditions. During
AZA treatments media was changed every 24 h and fresh
media with AZA was added. TSA was added 16–20 h before
cell harvest. Optimal drug concentrations and time periods
for each cell line were: HCT116 and DKO 0.5 M AZA
(72 h) and 0.3 M TSA; Caco-2, MDA-MB231 and A2780-
ADR 3 M AZA (96 h) and 0.5 M TSA; TOV112D 3
M AZA (72 h) and 0.3 M TSA. Somatic cell hybrids
were treated with 3 M AZA for 96 h and 0.3 M TSA
16–20 h before harvest. Chromosome 21 somatic cell hybrid
was treated for 72 h with AZA.
Actinomycin D (ActD) was used at final concentration of
5 g/ml. LS174T and DKO were harvested at 0, 0.5, 1, 2, 4
and 6 h after adding ActD. For RNA FISH purposes, ActD
was incubated 30′ for LS174T and DKO cells, and 4.5 h for
clone 12 and 48.
Metaphase FISH
Lymphocyte cells from a healthy donor (46XX) were pro-
cessed with HANABI Metaphase Chromosome Harvester
(ADS Biotec) in the Cytogenetic’s platform of the Hospi-
tal Germans Trias i Pujol. The probe for DNA FISH was
labeled with Biotin-dCTP (Life Technologies) by amplify-
ing an internal region of NBL2 with NBL2 Primer set 1 F
and Primer set 2 R. Conditions of amplification were as fol-
lows: 95◦C 2′; 40 cycles of 95◦C 45′′, 60◦C 45′′ and 72◦C
1′. A mixture of 150 ng probe, 7.5 g Cot-1 (Life tech-
nologies) and 10 g salmon sperm (Life technologies) was
ethanol precipitated. Pellet was dissolved in 20 l hybridiza-
tion buffer (Sigma). Metaphase chromosome spreads were
spotted onto glass slides. After RNase A treatment (200
g/ml in PBS, 1 h at 37◦C), denaturation was performed
with 70% formamide/2× SSC for 10′ at 75◦C. Slides were
washed in PBS and dehydrated through an ice-cold EtOH
increasing gradient (70%, 90% and 100% for 3′ each). PCR
probe mix was heated at 85 ◦C for 5′ to separate DNA
strands and applied to the slides. A coverslip was placed on
top of the probe, sealed with parafilm and incubated in a
humid chamber at 37◦C overnight (ON). Next day, prepa-
rations were submitted to stringency washes at 45◦C: two
washes in 50% formamide/0.5× SSC for 15′, two washes of
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5′ in 0.5× SCC and two washes in 0.5× SSC/0.1% Tween-
20 for 5′ each. Signal detection was performed with Tyra-
mide Signal Amplification kit (Life Technologies). Slides
were blocked with 1% BSA in PBS for 30′, and incubated
with 100 l Streptavidin antibody diluted in 1% BSA/PBS
(1:100, Life Technologies) for 30′ at RT. Finally, prepara-
tions were washed in PBS, incubated with 100 l Tyramide
labeled with Alexa Fluor 488 (1:1000) 5–10′ and washed 3×
in PBS. Slides were mounted with Vectashield medium con-
taining DAPI H-1200 (Vector Laboratories).
RNA extraction
RNA extraction was performed with miRNAeasy kit (Qia-
gen) or Maxwell LEV Simply RNA tissue kit (Promega) fol-
lowing manufacturer’s instructions. Extraction with miR-
NAeasy kit was followed by DNaseI treatment (DNA-
free kit, Ambion) according to manufacturer’s instructions.
Maxwell is an automated system for RNA extraction that
includes DNaseI treatment. Each sample was rigorously
tested for DNA contamination by qPCR after each extrac-
tion (see below). Accurate assessment of RNA quality from
CRC patients was done with Bioanalyzer (RNA Nano As-
say: 25–500 ng/l).
cDNA synthesis and qPCR analysis
Reverse transcription was performed with SuperScript® III
or IV First-Strand Synthesis System (Thermo Fisher Scien-
tific) with random hexamers (or oligo(dT) when indicated)
on 0.2–3 g of RNA. For strand-specific reverse transcrip-
tion 2 pmol NBL2 forward or reverse primer were added.
Relative expression was determined by quantitative poly-
merase chain reaction (qPCR) using SYBR Green I mas-
ter mix (Thermo Fisher Scientific) according to manufac-
turer’s instructions. Conditions of amplification were as fol-
lows: 95◦C 10′; 45 cycles of 95◦C 15′′, 60◦C 20′′ and 72◦C
25′′. Expression levels were normalized using PUM1 in cell
lines, PUM1 and BETA2 in CRC patients, GAPDH in so-
matic cell hybrids. A list of primers used in qPCR analyses
is summarized in Supplementary Table S1. Their efficien-
cies were compared to ensure analysis by the comparative
Ct method. Relative expression data was analyzed compar-
ing the Ct values of the gene of interest with Ct values of the
reference gene for every sample. We used the formula 2Ct,
Ct being the difference between the Ct of the RNA of
interest and the Ct of the housekeeping gene. Duplicates or
triplicates were made for each sample and primer set.
RNA fractionation
Protocol for RNA fractionation was performed as de-
scribed in (35). Cells were pelleted and lysed with 175 l/106
cells of cold Buffer 1 (50 mM Tris–HCl pH 8.0, 140 mM
NaCl, 1.5 mM MgCl2, 0.5% NP-40, 2 mM Vanadyl Ri-
bonucleoside Complex) and incubated 5′ on ice. Lysed cells
were centrifuged 2′ at 4◦C and 300 g. Supernatant (cytoplas-
mic fraction) and pellet (nuclear fraction) were kept on ice
and used for RNA extraction. In case of further fractionat-
ing to nuclear soluble and nuclear insoluble fractions, pel-
let was lysed with 175 l/106 cells of cold Buffer 2 (50 mM
Tris–HCl pH 8.0, 500 mM NaCl, 1.5 mM MgCl2, 0.5% NP-
40, 2 mM Vanadyl Ribonucleoside Complex) and kept on
ice for 5′. Lysate was centrifuged 2′ at 4◦C and 16 300 g. The
supernatant corresponds to the nuclear-soluble fraction.
The remaining pellet corresponds to the nuclear-insoluble
fraction. Total RNA from aqueous solutions (cytoplasmic
and nuclear-soluble fractions) was extracted with Qiagen
miRNAeasy kit, whereas the chromatin-associated fraction
was processed with the same kit according to instructions
for pellet extractions.
RNase R treatment
Treatment was performed essentially as described by Mem-
czak and colleagues (45). Briefly, total RNA from LS174T
cells was incubated with 3 U of RNase R (Epicentre
Biotechnologies) per g of RNA for 15′ at 37◦C. RNA
was purified with MEGAclear™ clean-up kit (Ambion), fol-
lowed by cDNA synthesis with SuperScript IV and qPCR.
Chromatin Immunoprecipitation (ChIP)
ChIP was performed with ChIP-IT® Express Enzymatic
Magnetic Chromatin Immunoprecipitation Kit and Enzy-
matic Shearing Kit (version F5, Active Motif), according to
instructions. Cells were crosslinked with 1% formaldehyde
for 10′ at RT, quenched with glycine (0.125 M) for 5′ at RT,
washed 2× with ice-cold PBS, scraped and pelleted by cen-
trifugation. Chromatin was enzymatically digested (Mna-
seI) for 8′ at 37◦C. Equal amounts of chromatin (100 g)
were diluted to 500 l with IP buffer and incubated with 3
g of desired antibody (H3K9ac (07-352, Millipore), total
H3 (ab1791, Abcam), control IgG (ab46540, Abcam)) ON
at 4◦C on a rotation wheel. DNA-antibody complexes were
recovered by adding protein A/G magnetic beads (Milli-
pore) for 2 h. After two washes with low salt buffer, 2 with
high salt buffer, 1 with LiCl buffer and a final wash with
TE (10 mM Tris pH 8.1, 1 mM EDTA), immunoprecip-
itated DNA was eluted, reverse crosslinked at 65◦C ON,
treated with RNAse A (10 g/ml) and proteinase K (200
g/ml), and purified by phenol chloroform extraction and
ethanol precipitation. Air-dried pellet was dissolved in 50
l of MilliQ water and 2.5 l were used for qPCR follow-
ing the same conditions described in qPCR analysis. Com-
parative Ct method relative to input material was used to
analyze the relative enrichment of histone marks at selected
genome regions.
Northern blots
We used DIG Northern Starter Kit from Roche for probe
preparation and chemiluminiscence detection according
to instructions. All buffers were prepared in RNAse-free,
DEPC treated ultrapure water (MiliQ H2O), and treated
with DEPC, when possible.
To prepare probe template, cDNA from HCT116
AZA/TSA treated cells was amplified with NBL2 specific
primers containing a T7 or T3 overhang in one of the
primers, depending on the desired direction of in vitro tran-
scription (IVT). IVT and DIG labeling were performed
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with MaxiScript (Ambion) and DIG-11-UTP (Roche) ac-
cording to instructions. The efficiency of DIG incorpora-
tion and concentration of the RNA probe was analyzed by
dot blotting serial dilutions of the prepared probe and con-
trol probe of known concentration (DIG Northern Starter
kit, Roche). We assured all RNA samples were not con-
taminated with gDNA by qPCR. Samples were prepared
by mixing 16 g of total RNA with an equal volume of
2× RNA loading buffer (Ambion loading buffer II mixed
with formaldehyde (Sigma) to final 8% formaldehyde), de-
natured at 67◦C for 10′, 94◦C for 1.5′ and chilled on ice for
1′. Denatured RNA samples were loaded on the denatur-
ing agarose gel (1.1% agarose (Roche), 6.6% formaldehyde
(Sigma) in 1× MOPS) and run at 80 V for ∼6 h in 1× MOPS
(20 mM MOPS (Sigma), 5 mM sodium acetate (Sigma),
2 mM EDTA (Ambion)). RNA was transferred onto a
positively charged nylon membrane (Roche) via capillary
transfer ON. The following day, the membrane was briefly
washed in 2× SSC (0.3 M NaCl (Sigma), 0.03 M sodium cit-
rate (Sigma), pH 7), and crosslinked by baking at 120◦C for
30′. RNA integrity and transfer efficiency was assessed by
staining the membrane with methylene blue. Membrane was
prehybridized in ULTRAhyb® Ultrasensitive Hybridiza-
tion Buffer (Ambion) for 1 h at 68◦C. Probe was denatured
by diluting 1:10 000 in ULTRAhyb® Ultrasensitive Hy-
bridization Buffer at 68◦C for 1′. Hybridization was per-
formed ON at 68◦C in a glass roller bottle. The following
day, membranes were washed 2× in low stringency buffer
(2× SSC, 0.1% SDS) for 5′ at RT, followed by 2 high strin-
gency washes (0.1× SSC, 0.1% SDS) at 68◦C for 15. Mem-
brane was washed in Washing buffer (0.1 M maleic acid,
0.15 M NaCl, pH 7.5, Tween-20 0.3% (v/v)) and blocked
in Blocking solution for 30′. Antibody solution containing
anti-digoxigenin-AP (1:10 000) was incubated 30′ at RT.
Membrane was washed 2× for 15′ in washing buffer, and
equilibrated in detection buffer (0.1 M Tris–HCl, 0.1 M
NaCl, pH 9.5) for 5′. Chemiluminiscence reagent CDP-Star
was added, and the membrane was exposed to an autora-
diography film (Sigma).
DNA extraction and bisulfite sequencing
DNA from pelleted cells was isolated with Maxwell Cell
DNA Purification kit. One microgram of DNA was trans-
formed with bisulfite using EZ DNA Methylation™ kit
(Zymo Research). One hundred fifty nanogram of bisulfite-
converted DNA was amplified with primers (designed con-
sidering C to T conversion) specific for an internal region of
NBL2 with FastStart High Fidelity PCR System (Roche)
as described previously (38). PCR products were cloned
into TA vector (Stratagene) and minipreps from ∼10–20
colonies were sanger sequenced using T7 or T3 primer. Se-
quences were aligned using CLC software. Alignments were
exported to BiQ Analyzer program to determine methyla-
tion of each CpG site.
Dual luciferase reporter assay
The insert of interest was obtained by PCR using a high-
fidelity polymerase (FastStart High Fidelity, Roche) with
primers having a restriction enzyme sequence overhang.
Fragments were designed to have different cloning sites on
each primer to ensure directionality of the cloning. Frag-
ments shorter than 2 kb were amplified using the follow-
ing conditions: 95◦C 2′; 40 cycles of 95◦C 30′, 59◦C 30′,
72◦C 2′; 72◦C 4′. Longer fragments were amplified accord-
ing to the following conditions: 95◦C 2′; 10 cycles of 95◦C
30′′, 59◦C 30′′, 68◦C 4′ 30′′; 30 cycles of 95◦C 30′′, 59◦C 30′′,
68◦C 4′ 30′′ adding 20′′ each additional cycle; 72◦C 7′. PCR
products were gel purified, cloned into pGL3-Basic plasmid
(Promega) and sequenced.
The insert and pGL3-Basic plasmid were digested with
two restriction enzymes (KpnI, HindIII or NheI; New Eng-
land Bioloabs) according to instructions. After digestion,
the plasmid was dephosphorylated using alkaline phos-
phatase. Plasmid and insert were ligated using T4 ligase
(NEB) in 1:3 ratio. Minipreps were prepared with Nucle-
oSpin Plasmid EasyPure kit (Macherey-Nagel). Plasmids
were sequenced to ensure the correct sequence and direc-
tionality of the insert.
DKO and LS74T cells were plated in a 12-well plate
in order to be 40–50% confluent at the time of transfec-
tion. For each transfection sample, the complexes were pre-
pared as follows: 50 ng pRL-CMV and 800 ng pGL3-insert
of interest were diluted in 100 l medium without serum.
Polyethylenimine (PEI) was diluted in 100 l medium with-
out serum. Solutions were incubated for 5′ at RT. The di-
luted DNA was combined with diluted PEI, and incubated
for 15′ at RT and finally 800 l medium without serum were
subsequently added to the mixture. Meanwhile, cells were
washed 2× with PBS. 200 l of the mixture were added to
each well. Media was changed with 1 ml medium + serum
after 5–6 h. Twenty four hours post-transfection, luciferase
reading was performed with Dual-Luciferase® Reporter
Assay System kit from Promega.
NBL2 3D DNA FISH/NPM1 immunofluorescence
3D DNA FISH was performed mainly as described in (46),
with changes in the detection system. The same probe was
used as for metaphase FISH. All washing steps were per-
formed at RT, if not otherwise noted. Briefly, coverslips
were coated with poly-L-lysine (10 g/ml) for 1 h. Follow-
ing coating, cells were seeded at desired confluence. On the
day of FISH, coverslips were washed 2× with PBS and
fixed in 4% paraformaldehyde for 10′, quenched in 0.1 M
Tris–Cl, pH 7.4 for 10′ and permeabilized for 10′ in 0.1%
saponin/0.1% Triton X-100 in PBS. After permeabiliza-
tion, cells were washed 2 × 5′ in PBS, and incubated in
20% glycerol/PBS for at least 20′. Subsequently, coverslips
were subjected to three freeze/thaw cycles in liquid nitro-
gen, washed 2 × 5′ in PBS and incubated in 0.1 M HCl for
30′, followed by 5′ wash in PBS. Coverslips were subjected
to second round of permeabilization in 0.5% saponin/0.5%
Triton X-100/PBS for 30′, washed 2× in PBS and equili-
brated in 50% formamide/2× SSC for at least 10′. 10 l
probe premix was spotted on a glass slide, and the cover-
slip was gently placed on the drop. Slides were heated for
2′ at 78◦C in order to denature simultaneously gDNA and
probe, and hybridization was left in a humid chamber ON at
37◦C. The following day coverslips were subjected to strin-
gency washes: 50% formamide/2× SSC 15′ at 45◦C; 0.2×
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SSC 15′ at 63◦C; 2× SSC 5′ at 45◦C; 2× SSC 5′ at RT;
short rinse in PBS. Signal development was performed with
Tyramide Signal Amplification kit (Life technologies) as de-
scribed in the Metaphase FISH section. If continuing with
immunofluorescence, cells were rinsed briefly in PBS, and
permeabilized in PBT (PBS 0.1% Tween-20) for 15′. Cells
were blocked for 30′ in 5% BSA in PBT. Cells were incu-
bated with the primary antibody for NPM1 (1:100) in PBT
5% BSA for 1 h, washed 3 × 5′ in PBT and incubated with
secondary antibody anti-mouse Alexa Fluor 594 (1:100) in
PBT 5% BSA. Cells were washed 3× in PBS and mounted
with Vectashield mounting medium containing DAPI H-
1200 (Vector Laboratories).
Single molecule RNA FISH
Single molecule RNA FISH was performed as described
in (47). A set of 48 custom tiled oligonucleotides labeled
with Quasar 570 targeting NBL2 transcript were designed
with LGC Biosearch Technologies’ Stellaris online RNA
FISH probe designer (Stellaris® Probe Designer version
4.2) and produced by LGC Biosearch Technologies. As con-
trols for proper hybridization to nuclear and cytoplasm
RNAs, two pre-designed probe sets labeled with Quasar 570
for GAPDH and MALAT1 (LGC Biosearch Technologies)
were used.
After coating glass coverslips with poly-L-lysine in PBS
(10 g/ml) cells were seeded at desired confluence. On the
day of RNA FISH, coverslips were washed 2× with RNase-
free PBS and fixed with 3.7% formaldehyde in PBS for 10′
at RT. After fixation, coverslips were washed 2× with PBS
and immersed in ice-cold 70% EtOH supplemented with
100 U/ml Superase RNase inhibitor (Ambion). Coverslips
were left in 70% EtOH on 4◦C up to 6 h. Coverslips were
briefly washed with 2 ml of Wash buffer A (LGC Biosearch
Technologies) at RT for 5′. In the case of RNase A treated
controls, prior washing with Wash buffer A cells were incu-
bated in 2 ml of RNase A (200 g/ml in PBS, 1 h at 37◦C).
Next, cells were hybridized with 100 l hybridization buffer
(LGC Biosearch Technologies) containing corresponding
probe (1:100) ON at 37◦C in a humid chamber. The follow-
ing day cells were washed with 1 ml of wash buffer A for 30′
at 37◦C, followed by another wash with wash buffer A con-
taining Hoechst DNA stain (1:1000, Sigma-Aldrich) for 30′
at 37◦C. For Stimulated Emission Depletion (STED) mi-
croscopy, nuclear stain was Picogreen instead of Hoechst.
Before mounting on a glass slide, cells were briefly (2–5′)
washed in 1 ml of wash buffer B (LGC Biosearch Technolo-
gies). Cells were mounted with ProlongGold (Life Tech-
nologies). Slides were left to curate overnight at 4◦C before
proceeding to image acquisition.
Coverslips intended for immunofluorescence and RNA
FISH were processed in the same way as described above,
with the following changes: (i) hybridization buffer con-
tained 1:100 dilution of NBL2 probe and 1:100 dilution of
primary antibody (NPM1, Abcam; SAM68, Santa Cruz)
and (ii) the first wash with wash buffer A after ON hy-
bridization contained 1:200 diluted anti-mouse or anti-
rabbit secondary antibody labeled with Alexa Fluor 488
(Abcam). For SAM68 intended for STED, secondary an-
tibody labeled with Abberior STAR 635 was used instead
of Alexa Fluor 488, and no DNA staining was applied.
NBL2 RNA/DNA FISH
Cells were seeded on poly-L-lysine coated 8-well glass Mil-
licell EZ SLIDE. TNBL single molecule FISH was carried
out as described in the previous section. At least 100 nuclei
were positioned and their coordinates were saved on wide-
field fluorescence microscope Olympus ScanR, with a 40×
0.75NA UPlan FL N objective and a Hamamatsu Orca-ER
camera. Subsequent DNA FISH was performed according
to the protocol previously described (48). Probe sequence,
probe preparation and probe signal detection was the same
as in the 3D DNA FISH approach. NBL2 DNA FISH
was imaged on the same positions used to sample TNBL
RNA. Alignment of images and observed drift correction
was done with FIJI plugin MultiStackReg v1.45. DAPI was
used as a reference to correct the drift that occurred between
the two imaging.
Microscopy and image analysis
Metaphase FISH images were obtained with wide-field
fluorescence microscope Olympus with 100×/1.3NA UP-
lanFL N objective. 3D NBL2 DNA FISH/NPM1 im-
munofluorescence zeta stacks were acquired with Zeiss
Axio Observer Z1 inverted confocal microscope using
63x/1.4NA DIC M27 objective. Images of Alexa fluor 488
were taken with 488 nm excitation and emission detection
between 498 and 584 nm. Pixel size was set to 80 nm. Im-
ages of Alexa fluor 594 were taken with 594 nm excitation
and emission detection between 604 and 704 nm. 3D stacks
were subsequently deconvolved using the Huygens decon-
volution software (Scientific Volume Imaging, SVI).
Single molecule RNA FISH and single molecule RNA
FISH/NPM1 immunofluorescence zeta stacks were ob-
tained with Zeiss Axio Observer Z1 wide-field fluores-
cence microscope using 63x/1.4NA DIC M27 objective. 3D
stacks were deconvolved using the Huygens deconvolution
software (Scientific Volume Imaging, SVI).
Confocal and STED images of NBL2 RNA FISH were
obtained on a Leica TCS SP8 STED 3X (Leica Microsys-
tems, Mannheim, Germany) on a DMI8 stand using a
100×/1.4NA HCS2 PL APO objective and a pulsed super-
continuum light source. The STED settings were chosen to
retain most part of lateral resolution and at the same time
provide some improvement in the axial dimension (20%
3D STED). Accordingly, multichannel 3D super-resolution
stacks were acquired at a pixel size of 26 nm and a z-step of
110 nm. Zoom was set at 5 in order to approximately fill the
image with one nucleus. Image size was set at 880 × 880 pix-
els, but whenever the nucleus shape and/or orientation was
favorable, image was cut in y to speed up the acquisition.
Scanner speed was set at 1000 Hz in bidirectional mode.
Confocal images of PicoGreen were taken with 488 nm ex-
citation and emission detection between 495 and 552 nm
without integration and average. Images of Quasar 570 were
taken with 556 nm excitation and emission detection be-
tween 562 and 650 nm. For STED imaging, a continuous
depletion laser at 660 nm was added at 100% intensity. The
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channels of 3D stacks were taken sequentially in a stack
by stack acquisition mode. 3D stacks were deconvolved us-
ing the Huygens deconvolution software (Scientific Volume
Imaging, SVI) for confocal and STED modes using shift
correction to account for drift during stack acquisition.
Confocal and STED images of NBL2 RNA FISH and
SAM68 immunofluorescence were taken on the same mi-
croscope using a 93 × 1.3NA Glyc HC CS2 PL APO ob-
jective with a motorized correction collar and a pulsed su-
percontinuum light source (’white light laser’). Given the
strong 3D component in the structures of interest, the
STED settings were chosen to maximize the resolution im-
provement in the axial dimension and at the same time
to retain some improvement in the lateral dimension (70%
3D STED). Accordingly, multichannel 3D super-resolution
stacks were acquired at a pixel size of 23 nm and with a z-
step of 68 nm. Pinhole diameter was set at 1 Airy Unit (AU)
for the confocal channels and at 0.6 AU for the STED chan-
nels. Zoom was set at 4 in order to approximately fill the
image with one nucleus. Image size was set at 1384 × 1384
pixels, but whenever the nucleus shape and/or orientation
was favorable, image was cut in y to speed up the acquisi-
tion. Scanner speed was set at 700 Hz in bidirectional mode.
The correction collar position was adjusted in every imaged
field to ensure the image quality throughout the whole im-
aged volume. Images of Quasar 570 were taken as described
previously. For STED imaging, a pulsed depletion laser at
775 nm was added with a 300 ps pulse delay at 50% intensity.
Confocal images were taken without integration and with
2× frame average; STED images were taken without inte-
gration and 3× frame average. Images Abberior 635 were
taken with 645 nm excitation and emission detection be-
tween 652 and 750 nm. For STED imaging, a pulsed de-
pletion laser at 775 nm was added with 300 ps pulse delay
at 30% intensity. Confocal images were taken without in-
tegration and with 2× frame average; STED images were
taken with 2× line integration and 3–4× frame average. The
channels of 3D stacks were taken sequentially in a stack by
stack acquisition mode. Once acquired, 3D stacks were de-
convolved and corrected for drift as described previously.
Confocal channels were acquired at the beginning of the
sequences to act as a reference for the drift correction of
STED channels.
TNBL RNA FISH and SAM68 immunostaining 3D ren-
dering was performed with Imaris software. Coordinates
(x, y, z) for each generated surface in Imaris were exported
and used to calculate the distances between centers of mass.
Xtension Kiss and Run was used to generate closest exterior
surface distances.
RNA affinity purification (RNA-AP)
RNA-AP was performed according to published protocols
from our collaborators (49). Briefly, 100–200 ng gel-purified
NBL2 monomer PCR product with T7 overhang was used
as a template for in vitro transcription (IVT) per 20 l of
IVT reaction. IVT was performed ON according to instruc-
tions (MEGAscript kit, Ambion) and Biotin-labeled using
Biotin-16-UTP (Epicentre). Probes were ethanol precipi-
tated and dissolved in water.
Cell pellet was resuspended in total protein lysis buffer
(20 mM Tris pH 7.4, 150 mM NaCl, 1.5 mM MgCl2,
2 mM DTT, 0.5% NP-40, 0.5% Na-deoxycholate, Com-
plete EDTA-free protease inhibitor (Roche), 100 U/ml Ri-
boLock (Thermo Scientific)). Protein extracts were pre-
cleared with Streptavidin Sepharose beads (GE Healthcare)
for 3 h at 4◦C rotating on a wheel, and supplemented with
0.1 mg/ml yeast tRNA and 100 U/ml RiboLock.
To block the beads, Streptavidin Sepharose Beads were
washed 2× with 500 l of WB-100 (20 mM HEPES pH7.9,
100 mM of KCl, 10 mM MgCl2, 0.01% NP-40 and 1 mM
of DTT) and blocked at 4◦C for 2.5 h with blocking buffer
(1 mg/ml of BSA, 200 g/ml Glycogen, 200 g/ml yeast
tRNA (Sigma) and wash buffer-100). Beads were washed
3× with 500 l of WB-300 (20 mM HEPES pH 7.9, 300 mM
of KCl, 10 mM MgCl2, 0.01% NP-40 and 1 mM of DTT),
transferred to a new tube and stored in WB-150 until the
preparation of protein extracts.
50 pmol refolded in vitro transcribed RNA (5′ at 65◦C; 15′
at RT, then transfer to ice) was added to pre-cleared pro-
tein extracts supplemented with tRNA & RiboLock and
incubated 1h at 4◦C on a rotating wheel. Afterward, 50
l of blocked beads were added to RNA-protein mix and
incubated for 1.5 h at 4◦C on a rotating wheel. Protein-
RNA-beads complexes were washed 5× with 1 ml WB-150
(20 mM HEPES pH 7.9, 150 mM of KCl, 10 mM MgCl2,
0.01% NP-40 and 1 mM of DTT) for 5′ at 7 rpm and 4◦C on
a rotating wheel. After the last wash, beads were transferred
to a fresh tube.
Proteins were eluted from the beads with 150 l elution
buffer (50 g/ml RNase A in WB-150) for 15′ on ice. Eluted
proteins were precipitated with ice-cold acetone ON at –
20◦C, pelleted, washed with 80% EtOH. Dry pellet was re-
suspended in 30 l 2× SDS sample buffer. 15 l was run on
SDS–PAGE gel. After silver staining the gel, band extrac-
tion of differentially enriched proteins and mass spectrom-
etry was performed at Core Facility for Mass Spectrometry
& Proteomics at ZMBH in Heidelberg, Germany. Data was
viewed and interpreted using Scaffold software.
Western blots
Pulled-down protein samples (5 l) were size separated on
SDS-polyacrylamide gel (9%) for 100′ at 120 V and trans-
ferred onto a PVDF membrane by electroblotting (75′ at
400 mA). The membrane blocked with 5% non-fat dry milk
ON at 4◦C. Membranes were subjected to immunoblot-
ting with the desired primary antibody (CELF1 1/2000
(sc-20003, Santa Cruz); NPM1 1/2000 (ab10530, Abcam);
RUVBL2 1/3500 (SAB4200194, Sigma); XRCC5 1/2000
(ab79391, Abcam); PTBP1 1/1000 (ab133734, Abcam);
NONO 1/300 (sc-376804, Santa Cruz); PLRG1 1/200 (sc-
376729, Santa Cruz) in TBST (0.5% Tween-20) for 4–5 h
at RT. Blots were incubated with Horse Radish Peroxidase-
conjugated secondary antibody (Polyclonal Goat Anti-
mouse Immunoglobulin/HRP (Dako Denmark); or Poly-
clonal Goat Anti-rabbit Immunoglobulin/HRP (Dako
Denmark)) diluted 1:10 000 in 5% milk in TBST for 1 h
at RT, washed 3× TBST and finally Pierce® ECL western
Blotting Substrate was added. Membranes were exposed to
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an autoradiography film (Sigma) inside a cassette and de-
veloped.
UV crosslink and RNA immunoprecipitation
Protocol was carried out mainly as described in (50) with
changes in the UV crosslink step according to Cabianca
et al. (35), and other minor changes. After washing the cells
(LS174T NBL2 low expressing and high expressing clone)
2× with ice-cold PBS, 10 ml of ice-cold PBS was added and
cells were UV crosslinked 2× with 100 000 J/cm2 with an
interval of 1′ between two irradiations.
Cell pellet was lysed on ice in lysis buffer (0.5% NP40,
0.5% Na-deoxycholate, 300 U/ml superase inhibitor (Am-
bion), protease inhibitor (Roche) in PBS, pH 7.9) and put
on rotation (25′ at 4◦C). 30 U of Turbo DNase (Ambion)
were added to the samples, incubated 15′ at 37◦C, and cen-
trifuged 15′ at 11 000 g at 4◦C. Supernatant was transferred
into a new tube and passed through a 45 m filter (Mili-
pore). For each RNA IP 500 g of lysate was dissolved in
lysis buffer to 200 l and precleared with 25 l of Dyn-
abeads Protein G. 2 g of antibody was added (CELF1
sc-20003, Santa Cruz; NPM1 ab10530, Abcam; RUVBL2
SAB4200194, Sigma; PLRG1 sc-376729, Santa Cruz) and
incubated ON at 4◦C on a rotation wheel. Ten percent of
precleared supernatant was saved as input. The following
day, 50 l of pre-washed Dynabeads G were added to each
tube and left on rotation for an additional hour. Beads were
washed 3× (5′ at 4◦C) with PBS supplemented with 1%
NP40, 0.5% Na Deoxycholate, additional 150 mM NaCl
(final 300 mM), and 1:200 Superase inhibitor (Ambion).
Beads were resuspended in 100 l of PBS + 10× DNase
buffer and 3 U of Turbo DNase (Ambion) were added.
Samples were incubated 30′ on rotation at 37◦C. Beads were
washed 3× (5′ at 4◦C) with 1% NP40, 0.5% Na Deoxy-
cholate, 10 mM EDTA, additional 150 mM NaCl (total 300
mM), 1:200 Superase inhibitor (Ambion) in PBS. RNA was
eluted in 100 l of elution buffer (100 mM Tris–HCl (pH
7.5), 50 mM NaCl, 10 mM EDTA, 100 g Proteinase K,
0.5% SDS) for 30′ at 55◦C, with shaking. After, samples
were centrifuged at 16 100 g at RT. The supernatant was
used for RNA extraction with Maxwell LEV Simply RNA
tissue kit (Promega). cDNA synthesis and qPCR were per-
formed as usual.
RESULTS
Pericentromeric NBL2 repeats from acrocentric chromo-
somes localize in the perinucleolar region
In the unlocalized GL000193.1 contig of the human refer-
ence genome hg37, the 1.4 kb NBL2 macrosatellite unit is
repeated in tandem 21 times (Supplementary Figure S1A).
Each repeat starts with a GA-rich sequence and CA dinu-
cleotide repeats of variable length. These 21 NBL2 repeats
share between 90 and 99% identity except for the truncated
repeat 21 (Supplementary Figure S1B). To facilitate assess-
ing the consequences of NBL2 hypomethylation we set out
to determine more precisely its genomic location by PCR
on human-rodent somatic cell hybrids. All NBL2-specific
primer sets amplified NBL2 sequences from chromosomes
9, 13, 14, 15 and 21. Of note, four of these chromosomes
are acrocentric (Figure 1A). Less robust signals with lower
intensity or from less primer pairs came from chromosomes
7, 12, 20 and Y, suggesting that these chromosomes contain
fewer copies or more divergent NBL2 repeats (Figure 1A).
Quantitative PCR (qPCR) with primer sets amplifying a
smaller region of NBL2 indicated that acrocentric chromo-
somes 13, 14, 15 and 21 carry NBL2 in a higher copy num-
ber (table in Supplementary Figure S1C). Chromosomes 13,
14, 15 and 21 also shared DNA sequences adjacent to the
NBL2 repeat cluster, which allowed to roughly estimate the
NBL2 relative abundance between these chromosomes. In
human-rodent somatic cell hybrids, chromosome 13 had the
highest copy number of NBL2 repeats, followed by chromo-
some 21 and 15 (graphic in Supplementary Figure S1C).
Next, we studied the NBL2 location by performing DNA
FISH on metaphase chromosomes from lymphocytes of a
healthy donor. Hybridization signals were detected close to
centromeres in the short arm of chromosome 21, and any
two of the PCR-positive chromosomes 13, 14 or 15, diffi-
cult to distinguish by DAPI staining due to their similarity
(Figure 1B). These results extend previous findings (39,51)
and add a more precise information on NBL2 localization
and quantitative variation.
While performing this study, contig GL0000193.1 was in-
corporated into genome built hg38 and mapped to chro-
mosome 21. In silico analysis performed using a consensus
NBL2 sequence obtained from the 21 monomers revealed
a total of 301 hits (Figure 1C). Most conserved copies (80–
100% similarity to the NBL2 consensus) are located in the
pericentromeric regions of chromosomes 7, 9, 12, 20 and
21 (Figure 1C, green circles), partially coinciding with our
PCR results on human-rodent somatic cell hybrids. More
divergent copies are placed in the pericentromeric regions
of chromosomes 1, 7, 9, 12, 16, 17, 18, 20, 22 and Y; and
in the long arm of chromosomes 4 and 19. Some chromo-
somes carry homogenous tandem arrays, while other chro-
mosomes have tandem arrays of NBL2 with variable levels
of similarity. The absence of mapped NBL2 repeats from
acrocentric chromosomes 13, 14 and 15 (Figure 1C), in con-
trast with our experimental data (shown in Figure 1A, 1B
and Supplementary Figure S1C) highlights the fact that
DNA repeats are still poorly assembled in the reference
genome.
To study the spatial distribution of NBL2 repeats on
interphase nuclei, we performed NBL2 DNA FISH with
the same probe used for the metaphase FISH (Figure 1B),
followed by immunofluorescence against nucleophosmin
(NPM1), a nucleolus marker. Most detected dots (92%) as-
sociated with the nucleolus in HCT116 CRC cells (Figure
1D). More precisely, 3D visualization showed that NBL2
repeats from acrocentric chromosomes were located in the
perinucleolar region (Figure 1D, right).
NBL2 is transcribed, when de-regulated by DNA demethyla-
tion and histone acetylation
DNA methylation at CpG sites is a potent repressor of gene
expression. NBL2 sequences have high GC content (62%,
Supplementary Figure S1A), a high observed to expected
CpG ratio (82%) and are highly methylated in normal so-
matic cells (52). Thus, we hypothesized that hypomethyla-
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Figure 1. NBL2 distribution in the human genome. (A) NBL2 PCR analysis on DNA from human-rodent somatic cell hybrids containing a single human
chromosome isolated in a rodent background. Top: in pink are represented the regions amplified by four NBL2 specific primer sets located across the repeat
unit. Bottom: PCR products of each primer set from genomic DNA of somatic cell hybrids containing the indicated human chromosome. (B) NBL2 DNA
FISH on metaphase spreads from leukocytes of a healthy donor (46XX). Hybridization signals were detected close to the centromeres in the short arms
of acrocentric chromosomes 13, 14, 15 and 21 (n = 30). NBL2 in green, DAPI in grey. (C) Ideogram showing genome-wide distribution of NBL2 repeats
in the human genome version hg38. 301 hits were color-grouped according to their similarity to NBL2 consensus sequence. Acrocentric chromosomes
positive for NBL2 by PCR (A) and FISH (B) are highlighted by a colored box. (D) NBL2 DNA FISH (green) and NPM1 immunofluorescence (magenta)
on interphase nuclei (grey) of HCT116 cell line. 3D view (on the right) shows NBL2 repeats from acrocentric chromosomes located in the perinucleolar
region. On average, each nucleus contained 8 NBL2 FISH signals, with 92% of detected signals located adjacent to nucleolus (n = 30 nuclei).
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tion of non-coding NBL2 sequences could lead to their ex-
pression. We analyzed expression of NBL2 by RT qPCR in
CRC cell lines. NBL2 expression was almost undetectable in
CRC cell lines harboring highly methylated NBL2 (Caco-2,
HCT116) whereas hypomethylated NBL2 (in LS174T cells)
were transcribed (Figure 2A). Treatment with the DNA
hypomethylating agent 5-aza-2′-deoxycytidine (AZA) re-
sulted in increased NBL2 transcription in both methylated
cell lines, in a time-dependent manner (Figure 2B).
In contrast, treatment with the histone deacetylase in-
hibitor Trichostatin A did not affect NBL2 transcript lev-
els by itself but synergized with AZA treatment in both
HCT116 and Caco-2 cells (Figure 2C, upper panel, Supple-
mentary Figure S2A). Accordingly, increased transcription
in AZA/TSA treated cells was associated with increased
acetylation of histone H3 at lysine 9 (H3K9ac) at NBL2
sequences (Figure 2C, bottom right). Collectively, these
data show that DNA methylation and histone deacetyla-
tion maintain NBL2 repressed, with DNA methylation as a
dominant suppressor mark. The same result was observed
in ovarian (A2780-ADR, TOV112D) and breast (MDA-
MB231) cancer cell lines (Supplementary Figure S2B–D)
showing the generalization of the repression mechanism.
NBL2 transcripts were compared with the levels of the
housekeeping gene PUM1 (Pumilio RNA Binding Fam-
ily Member 1), frequently used to normalize expression in
CRC cell lines. NBL2 RNA levels were comparable to the
levels of PUM1 mRNA (in Caco-2 cells, Supplementary
Figure S2A middle), or even surpass them tenfold (HCT116
cells, Figure 2C, top right). Similar profile was observed in
ovarian and breast cancer cell lines (Supplementary Figure
S2B–D) again showing a general pattern of behavior in hu-
man cancer cells.
The relationship between NBL2 DNA methylation and
acetylation in regulating its expression was analyzed in
HCT116 DNMT1 and DNMT3b double knockout cells
(DKO) that have strongly reduced global DNA methylation
(53). NBL2 repeats were almost completely unmethylated
and transcribed in DKO cells compared with HCT116 cells,
thus excluding that the overexpression originated from a
non-specific effect of AZA (Figure 2D). While AZA did not
further increase expression, TSA-induced levels of NBL2
expression were higher than in HCT116 AZA/TSA treated
cells (compare NBL2 expression in Figure 2D with 2C).
NBL2 repeats are also transcribed in primary CRC specimens
To test whether expression also co-occurs with NBL2 hy-
pomethylation in primary cancers, we analyzed two groups
of primary CRC and matched normal tissues (Figure 3).
The results showed NBL2 over-expression in 3 out of 37
primary CRC (8.1%), resembling the frequency of severe
NBL2 hypomethylation (7%) that we previously described
(38). One tumor (727T, Figure 3, group 1) did not show
severe hypomethylation of NBL2, suggesting that somatic
NBL2 DNA hypomethylation and overexpression are re-
lated, but not in a linear dependent manner. However, we
cannot rule out that increasing sequencing depth would un-
veil completely unmethylated sequences in tumor 727. Dis-
ruption of histone deacetylation at moderately hypomethy-
lated NBL2 elements may induce strong NBL2 expression.
Since NBL2 RNA is detected upon DNA demethylation
in cancer, we designated these transcripts TNBL (Tumor-
associated NBL2 transcript).
TNBL is a nuclear, non-polyA, stable, long non-coding RNA
TNBL was amplified from random primed cDNA but not
from oligo(dT), similarly to non-polyA 18S rRNA, indicat-
ing that TNBL lacks a polyA tail (Figure 4A). TNBL was
enriched in reverse transcriptase reactions primed with an
NBL2-specific forward oligonucleotide and not with a re-
verse primer, implying that transcription occurs in the anti-
sense direction of the repeat (Supplementary Figure S3A).
TNBL was enriched in the nuclear fraction, more specifi-
cally in the nuclear insoluble fraction (Figure 4B and Sup-
plementary Figure S3B).
In mammalian cells, a major step triggering mRNA de-
cay is the removal of the 3′-poly(A). TNBL lacks poly(A),
therefore it could represent an unstable run-through RNA.
To determine TNBL stability, cells expressing TNBL en-
dogenously (LS174T and DKO) were treated with the tran-
scription inhibitor Actinomycin D (ActD). TNBL stability
showed a similar profile to that of mature RNA of PUM1,
lncRNA MALAT1, and GAPDH (Figure 4C, Supplemen-
tary Figure S3C) in contrast with the pre-mature form of ri-
bosomal RNA (45S rRNA) that was depleted after 30 min
of ActD treatment. This result shows that TNBL is a sta-
ble transcript and that the regions monitored by RT qPCR
form part of a mature RNA molecule. Next, we analyzed
the TNBL length by Northern blots on RNA from CRC
(Caco-2, HCT116, DKO) and ovarian cancer (TOV112D)
cell lines treated with AZA and AZA/TSA, and in LS174T
that contains unmethylated NBL2. Antisense probes did
not give a hybridization signal (not shown) confirming the
antisense direction of transcription. Two sense probes, de-
signed against two different regions of the NBL2 repeat
(Supplementary Figure S3D), hybridized against two high
molecular weight RNAs of approximately 13 and 10 kb,
and a lower of 4.2 kb (Figure 4D). These bands were ab-
sent in Caco-2, HCT116 and TOV112D untreated cells (all
having methylated NBL2), and increased after treatment
with AZA and AZA/TSA, coincident with the RT qPCR
results. Furthermore, relative enrichment of those bands be-
tween the cell lines after AZA/TSA treatment is consistent
with RT-qPCR data, with Caco-2 levels being the lowest.
Similar band patterns were displayed by untreated LS174T,
showing that the transcripts induced by AZA/TSA treat-
ment corresponded to the endogenous transcripts.
Three observations suggest that these transcripts include
complete NBL2 monomers. First, both probes designed at
opposing ends of the NBL2 monomer detected similar pat-
terns of the differently sized transcripts (Figure 4D). Sec-
ond, entire NBL2 monomers were amplified from cDNA
with two different primer pairs (Supplementary Figure
S3E). Third, PCR with primers amplifying the join region
of adjacent monomers indicated that more than one repeat
unit may be included in at least one of the two major tran-
scripts (Supplementary Figure S3E). This ‘cross-boundary’
PCR together with TNBL’s high stability and lack of polyA
tail, could be explained by a circular RNA molecule. How-
ever, TNBL was not resistant to treatment with exonuclease
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Figure 2. DNA methylation and histone deacetylation maintain NBL2 repressed. (A) Left: NBL2 methylation assessed by bisulfite sequencing in 3 CRC
cell lines. Right: relative NBL2 expression analyzed by RT qPCR in CRC cell lines. (B) Left: NBL2 expression analyzed by RT qPCR in HCT116 cell line
untreated (NT) and treated with AZA for 72h. Right: NBL2 expression analyzed by RT qPCR in Caco-2 cell line untreated (NT) and treated with AZA
in a 5-day time course experiment. (C) Upper left: NBL2 expression assessed by RT qPCR in HCT116 cell line untreated (NT), treated with AZA, treated
with AZA followed by TSA, and treated with TSA only. Upper right: relative abundance of NBL2 transcript compared to PUM1 levels (assigned as 1 in
each sample) within each treatment group. Lower left: NBL2 methylation assessed by bisulfite sequencing in each treatment group. Each dot represents the
average methylation of one NBL2 bisulfite converted sequence. Lower right: H3K9ac chromatin immunoprecipitation at NBL2 loci. Enrichment levels were
normalized with H3 total levels at NBL2 loci. (D) Top left: NBL2 methylation assessed by bisulfite sequencing in HCT116 and DKO. Each dot represents
the average methylation of one NBL2 bisulfite converted sequence. Top right: NBL2 methylation in HCT116 and DKO represented by a lollipop graph.
Each line represents the internal region of 1 bisulfite converted NBL2 cloned DNA molecule. White and black circles: unmethylated and methylated
CpGs, respectively. Lower left: RT qPCR of NBL2 in HCT116 untreated, DKO untreated, DKO treated with AZA and DKO treated with TSA. Lower
right: relative abundance of NBL2 transcripts compared to PUM1 levels (assigned as 1 in each sample). All qPCRs show relative levels obtained using
comparative Ct method and normalized with PUM1.
RNAse R, behaving different from a circular RNA control
(hCIRC 1 (45)) and similar to non-circular RNAs such as
PUM1 and GAPDH (Supplementary Figure S3G).
TNBL originates from chromosomes 13, 14, 15 and 21
To determine the origin of TNBL detected by RT qPCR
and Northern blot approaches, cell hybrids found positive
for NBL2 DNA amplification (9, 12, 13, 14, 15, 20, 21, Y)
plus several negative controls (hybrids containing chromo-
somes 1, 11 and X) were treated with AZA and AZA/TSA,
and TNBL expression was measured by RT qPCR. Chro-
mosome 21 showed the highest expression of TNBL upon
demethylation and histone acetylation, followed by chro-
mosomes 15, 14 and 13 (Figure 4E). Of note, none of the
primers, which also recognized NBL2 from chromosomes
9, 12, 20 and Y (Figure 1A), amplified any RNA from these
chromosomes (Figure 4E). Furthermore, and consistent
with the RT qPCR data, chromosome 9 that contains sev-
eral NBL2 copies intermingled with NBL2-like sequences
(Figure 1C), did not give rise to any band detectable with a
5514 Nucleic Acids Research, 2018, Vol. 46, No. 11
Figure 3. NBL2 somatic DNA hypomethylation predisposes for NBL2
overexpression in CRC. NBL2 expression analyzed in 2 CRC groups.
Group 1 (24 tumor and matching normal tissue samples) analyzed for
NBL2 expression by RT qPCR (top) and methylation by bisulfite sequenc-
ing (bottom). Three representative cases are shown: two cases (727 and 33)
with NBL2 overexpression in the tumor and one case (700) with no de-
tectable NBL2 expression. Group 2 (13 tumor and matching normal tis-
sue samples) analyzed for NBL2 expression by RT qPCR (top) and NBL2
DNA methylation by bisulfite sequencing (bottom). In methylation graphs
each dot represents average methylation of an internal region of 1 NBL2
bisulfite converted sequence. Red dots for tumor, grey dots for normal. Pie
chart shows the percentage of patients expressing NBL2 considering both
groups (n = 37). Statistical analysis was not performed due to low number
of samples.
TNBL specific Northern blot probe (Figure 4D, probe 2).
Northern blots on hybrids expressing TNBL upon induc-
tion with AZA/TSA showed that both transcripts of 13 and
10 kb originate from all four acrocentric chromosomes (Fig-
ure 4F). The absence of band 4.2 kb together with its local-
ization close to the 28S rRNA, questions whether this is a
real transcript or could represent an artifact due to impaired
migration of degraded transcripts, an issue that will have
to be determined. H3K9ac chromatin immunoprecipitation
on untreated, AZA and AZA/TSA hybrid cells containing
chromosome 21 confirmed the enrichment of histone acety-
lation at NBL2 repeats upon AZA/TSA treatment (Supple-
mentary Figure S3F). Collectively, these results show that
the regulation of TNBL expression from each of the four
chromosomes harboring the highest copy number of NBL2
macrosatellites is conserved in the rodent cellular environ-
ment and that TNBL can originate from chromosomes 13,
14, 15 and 21. Whether chromosomes harboring NBL2-
like sequences (for instance non-pericentromeric repeats at
chromosome 4), are expressed under normal conditions or
in cancer environment was beyond the scope of this study
and remains to be analyzed.
NBL2 repeats contain promoter activity
The strong induction upon AZA and AZA/TSA treat-
ments, combined with the expression of transcripts of pre-
cise size, suggested the existence of a specific transcription
start site and a strong promoter. There is a cluster of trun-
cated retrotransposons spanning 10 kb at 3′ of the anno-
tated NBL2 MSR of chromosome 21 (see scheme in Fig-
ure 4G, Supplementary Figure S1A). As these TEs are lo-
cated 5′ of the observed transcriptional direction, we de-
cided to analyze their potential promoter activity by lu-
ciferase reporter assays. Several fragments containing these
transposable elements, and 11 distinct NBL2 monomers
from chromosome 21 were individually cloned and tested
in DKO (Figure 4G). These truncated forms of retrotrans-
posons did not elicit >2-fold promoter activity compared
with the empty vector. On the other hand, NBL2 monomers
consistently yielded higher promoter activities than TEs,
with the highest activity from some monomers only 3-
fold lower than the strong CMV positive control promoter.
The average luciferase activity of all monomers was sig-
nificantly higher than that of TEs (P = 3.9E–03, Mann-
Whitney-Wilcoxon Test). These results suggest that some
NBL2 monomers harbor internal functional promoters.
TNBL accumulates as a perinucleolar aggregate at NBL2
loci
To analyze TNBL localization in the three-dimensional nu-
clear space, we performed single molecule RNA FISH.
HCT116 nuclei showed upregulation of TNBL signals
upon AZA treatment, which were further enhanced by
AZA/TSA (Supplementary Figure S4A). TNBL appeared
widely distributed in the nucleus with several focal, bright
signals. Quantification of TNBL signals showed 0 to 2 dots
per nucleus in untreated HCT116 cells, while AZA and
AZA/TSA treated HCT116 cells showed 2–30, and 7–75
dots per nucleus, respectively.
In TNBL endogenously expressing cells LS174T and
DKO, TNBL appeared exclusively nuclear, preferentially as
an aggregate located in the perinucleolar region (Figure 5A
for LS174T, Supplementary Figure S5A for DKO). TNBL
aggregates were more abundant in LS174T than in DKO. In
both cell lines, TNBL aggregates could not be resolved well
using wide-field or confocal microscopy. To better resolve
the structure of the aggregates, we used Stimulated Emis-
sion Depletion (STED) super-resolution microscopy. The
results show that these aggregates contain high amounts
of TNBL molecules (Figure 5B and Supplementary Figure
S5B). TNBL was also dispersed across the nucleus, more ev-
ident in LS174T cells that express higher amounts of TNBL
compared with DKO (compare Figure 5B with Supplemen-
tary Figure S5B).
To analyze whether TNBL aggregates represent nascent
or mature transcripts, RNA FISH was performed on DKO
and LS174T cells treated with the RNA polymerase in-
hibitor actinomycin D (ActD). After 30 minutes of treat-
ment TNBL aggregates were still present, indicating they
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Figure 4. TNBL is a long, non-polyA, nuclear and stable transcript. (A) TNBL RT qPCR of oligo(dT) or random primed cDNA from HCT116 (left)
and Caco-2 (right) AZA and TSA treated cells. Control RNAs: PUM1 as a polyA containing RNA and 18S rRNA as a non polyA containing RNA. (B)
Relative enrichment (in %) of TNBL, XIST and PUM1 transcripts in nuclear insoluble, nuclear soluble and cytoplasmic RNA fractions from AZA and
TSA treated Caco-2 cells analyzed by RT-qPCR. (C) TNBL stability relative to GAPDH RNA measured by RT qPCR at several time points in LS174T
cells treated with Actinomycin D (ActD) during a 6 h time course using two NBL2 specific primer sets (1 and 3). PUM1 and MALAT1 were used as
controls of mature RNA, and 45s rRNA of pre-mature RNA. (D) Left: TNBL sense probe 1 Northern blot on RNA from untreated (NT), AZA and
AZA/TSA treated Caco-2, HCT116 and TOV112D cells. RNA from mouse C2C12 myoblasts treated with AZA/TSA was used as a negative control.
Middle: TNBL sense probe 2 Northern blot on RNA from HCT116 untreated (NT) and AZA/TSA treated, DKO untreated and TSA treated. Negative
control: chromosome 9 human-rodent somatic cell hybrid treated with AZA/TSA. Right: TNBL sense probe 2 Northern blot on RNA from LS174T cells.
Sample integrity and equal loading was assessed with 18s and 28s rRNA methylene blue staining. (E) NBL2 expression analyzed with RT qPCR in human
rodent somatic cell hybrids untreated (NT), AZA treated, and AZA/TSA treated. (F) Northern blot on RNA from chromosome 13, 14, 15 and 21 human
rodent somatic cell hybrids untreated and AZA/TSA treated. Sample integrity and equal loading was assessed with 28s rRNA methylene blue staining.
(G) Scheme of DNA fragments cloned into pGL3-basic vector driving luciferase gene expression (LUC). Promoter activity was analyzed in DKO cells.
NBL2 array is represented 3′ to 5′. 16 different constructs were analyzed: 10 different NBL2 monomer sequences (1.4 kb each); a monomer 21 (928 bp,
truncated monomer); a monomer 21 with adjacent transposon elements (TE1: L1MD2-MLT1D); and four fragments encompassing distinct transposon
element upstream regions: TE1 (L1MD2-MLT1D), TE2 (MLT1D-MER70-int), TE3 (LTR7-MER70A), TE4 (LTR7). The graph shows relative luciferase
activity of tested fragments compared to empty vector. P = 3.9E–03, as evaluated by Mann-Whitney-Wilcoxon test.
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Figure 5. TNBL is a perinucleolar, stable RNA. (A) Maximum intensity projections of TNBL RNA FISH (yellow) and NPM1 immunofluorescence
(magenta) in LS174T cells. TNBL forms clusters adjacent to the nucleolus, with typically one or two clusters per nucleus. All of the clusters were located
in the perinucleolar region (n = 50 nuclei). DNA shown in grey. Zeta stacks were acquired with a wide-field microscope and deconvolved with Huygens
deconvolution software. Scale bar, 5 m. (B) Maximum intensity projections of confocal and stimulated emission depletion (STED) imaging of TNBL
RNA FISH (yellow) in LS174T cells. DNA in blue. Scale bar, 5 m. (C) Maximum intensity projections of TNBL RNA FISH in untreated LS174T cells
and treated with Actinomycin D (ActD) for 30 min and 4.5h. Zeta stacks were acquired with a wide-field microscope. TNBL in yellow, DNA in blue. On the
right: quantification of clustered TNBL (labelled as C) and dispersed TNBL (labelled as D) in all treatment conditions. 4.5h treatment with Actinomycin
D results in total depletion of TNBL clusters and significant increase in dispersed TNBL signals (***P ≤ 0.001, as evaluated by unpaired t-test versus 30′
ActD or NT; n = 50 nuclei). (D) NBL2 DNA/RNA FISH. NBL2 in magenta, TNBL in yellow. Bar plot (n = 70 nuclei) shows the percentage of NBL2
loci co-localizing with TNBL clusters (N–C), and the percentage of TNBL clusters co-localizing with NBL2 loci (C–N). Nucleus border is outlined with
a dashed line. (E) TNBL during mitosis detected by RNA FISH in LS174T high expressing clones. TNBL in yellow, DNA in gray. Scale bar, 5 m.
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were accumulations of mature transcripts (Figure 5C, Sup-
plementary Figure S5C and D). Numerous TNBL tran-
scripts were present during mitosis even though cells were
treated with ActD, emphasizing TNBL stable nature (Sup-
plementary Figure S5D, red arrow). Longer periods of
ActD treatment (4.5 h) disrupted TNBL perinucleolar ag-
gregates, releasing multiple TNBL transcripts that remained
exclusively nuclear, suggesting that active transcription was
necessary for aggregate formation.
In contrast with TNBL, the NBL2 MSR loci from chro-
mosomes 13, 14, 15 and 21 were not clustered in the nu-
cleus (Supplementary Figure S5E). Thus, TNBL could be
expressed only from one chromosome, or from several acro-
centric chromosomes, but accumulating in only one region.
To address this issue, we performed NBL2 DNA/RNA
FISH (Figure 5D). TNBL aggregate co-localized with one
NBL2 loci in 90% of instances (bar plot in figure 5D, n = 70,
quantified in 7 randomly selected fields). In contrast, from
the eight NBL2 loci consistently detected by our FISH ap-
proach in interphase nuclei (corresponding to the two alle-
les of chromosomes 13, 14, 15 and 21) only around 20% co-
localized with the TNBL aggregate. These results demon-
strate that TNBL aggregates only accumulate around a sub-
set of NBL2 loci, probably those that originate the tran-
script. Additional fainter TNBL signals (not aggregates) are
dispersed in the nuclei and do not co-localize with NBL2
loci (Figure 5D).
All together, these results demonstrate that TNBL has
a consistent location in the nucleus, with the vast major-
ity accumulating at a subset of NBL2 loci, forming densely
packed aggregates.
As controls, MALAT1 and GAPDH RNA FISH were
coupled with NPM1 immunofluorescence (Supplementary
Figure S6A), and confirmed the specificity of TNBL RNA
FISH and immunostaining approach, showing MALAT1
characteristic localization in the nucleus (54), and GAPDH
in the cytoplasm.
TNBL expression during mitosis
LS174T cells showed TNBL heterogeneity with some cells
harboring high TNBL levels visible by RNA FISH. We
monitored the behavior of TNBL expression during mito-
sis in clones expressing homogenously high TNBL levels
(Figure 5E). When chromatin started to condense in early
prophase, the TNBL aggregate was still present. However,
in late prophase, the aggregate disassembled and multiple
transcripts were released into the cytoplasm of the dividing
cell. This again shows the high quantity of TNBL molecules
retained within the aggregate. This process coincides with
the timing of disassembly of the nuclear envelope and most
of nuclear bodies such as the nucleolus (55). TNBL tran-
scripts were present during metaphase outside the chro-
matin fraction and were transferred into daughter cells in
anaphase. Once chromatin started to decondensate at the
end of telophase, the majority of TNBL was located in the
nucleus.
To summarize, these results show that TNBL is fre-
quently detected as clusters of mature stable RNAs that
transiently disaggregate during mitosis and after prolonged
inhibition of RNA polymerases.
TNBL aggregate accumulates tightly adjacent to the SAM68
nuclear body
Since TNBL forms aggregates in the perinucleolar region,
we investigated whether it associates with the two nuclear
bodies described in the perinucleolar region: the perinu-
cleolar compartment (PNC), consisting mainly of PTBP1
and CELF1 RNA binding proteins (56,57), and the SAM68
nuclear body (SNB), enriched in SAM68 RNA binding
protein, among others (58,59). Both PNC and SNB ap-
pear preferentially in tumor cells and rarely in normal cells
and their occurrence has been positively linked with the
metastatic capacity (60,61). We performed TNBL RNA
FISH in concert with CELF1 and SAM68 immunofluores-
cence in LS174T cells. CELF1 PNCs were not detectable by
immunofluorescence (data not shown), while formation of
SNBs was detected in all nuclei (Figure 6A). In addition to
form SNBs, SAM68 is also diffusely distributed in the nu-
cleus (lighter magenta staining outside SNBs in Figure 6A,
B, D) in accordance with previous reports (58). The results
showed that the TNBL aggregate consistently localized ad-
jacent to SNB (Figure 6A).
By STED microscopy TNBL and SAM68 structures ap-
peared in a tight lateral interaction and seemed to have
similar shapes. Most of the times both structures had an
irregular round form (Figure 6B, top image). In some in-
stances, they acquired an elongated form, and in those cases
both structures seemed specular images (Figure 6B, bot-
tom image). 3D rendering illustrated their interaction in
the proximal boundaries, and the same starting and end-
ing point of the lateral interaction (Figure 6B). Proximity
calculations revealed that mass centers between TNBL clus-
ters and SNBs were maintained within a 0.23–2.15 m dis-
tance range, with a median value of 0.92 m (Figure 6C
left graph). Furthermore, the majority of the closest ex-
terior distances between TNBL aggregates and SNB sur-
faces were 0 m (28 out of 54 analyzed surfaces), with little
to no overlap, while the maximum distance measured was
0.42 m (Figure 6C, right graph). The maximum resolution
achieved with our STED settings was approximately 40 nm
lateral and 100 nm axial. Based on this analysis we conclude
that the TNBL-SNB interaction is robust. These structures
did not seem to imbricate into each other but rather they
appeared to have opposite surfaces possibly adjoined by a
linker structure.
In two TNBL high expressing clones TNBL-SAM68 ag-
gregates were also present (Figure 6D). In clone 1 that
showed more than one SNB per nucleus, all and each of
the TNBL aggregates were located adjacent to SNBs (Fig-
ure 6D upper panel) showing an apparent interdependence.
However, SNBs were not always accompanied by TNBL
clusters (Figure 6A white arrows). GAPDH and lncRNA
MALAT1 control RNA FISH coupled with SAM68 im-
munofluorescence, reinforced the specificity of the TNBL
distribution adjacent to SAM68 bodies (Supplementary
Figure S6B).
In RNA immunoprecipitation of UV-crosslinked cells,
TNBL appeared enriched in SAM68 pull-downs compared
to the negative control RNA U1 snRNA (Figure 6E). This
result further supports the close interaction between TNBL
aggregates and SAM68-enriched SNBs.
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Figure 6. TNBL forms aggregates adjacent to SAM68 perinucleolar body
(SNB). (A) Maximum intensity projection of SAM68 IF (magenta) and
TNBL interacts with CELF1 and NPM1
To identify additional proteins interacting with TNBL we
used RNA affinity purification (RNA-AP) coupled to pro-
tein identification by mass spectrometry. Biotin-labeled
and unlabeled NBL2 monomer-derived in vitro transcripts
(IVTs) were incubated with total protein extracts from three
different CRC cell lines. As negative controls, two IVTs of
the lncRNA MALAT1 of the same size and GC content
were used.
A number of protein bands specifically enriched in NBL2
IVT pull-downs were observed after gel electrophoresis and
silver staining (Figure 7A). By visual inspection, we se-
lected bands on the gel differential between NBL2 IVT
and MALAT1 IVT controls in three different cell lines
(DKO TSA, Caco-2 and LS174T). Bands 1 to 16 numer-
ically labelled on top of the RNA-AP gel (arrows in Fig-
ure 7A) indicate consistent bands present in all three cell
lines, which serve as biological replicates, that were not en-
riched in MALAT1 IVT control pull downs. The gel was
cut in slices containing these differential bands (arrows in
Figure 7A) and each band from two cell lines was analysed
in order to have a biological replica of the mass spectrom-
etry. After mass spectrometry analysis of each slice, known
contaminants and proteins of inappropriate size were ex-
cluded. Since TNBL is only present in the nucleus, we also
discarded cytoplasmic proteins. After these exclusions, the
remaining proteins were ranked according to their preva-
lence in the respective band (by peptide count). Gel bands
indicated in Figure 7B contained the top 20 ranked proteins,
which included many candidates in the category of DNA re-
pair, chromatin remodeling and RNA metabolism, such as
stability and splicing (Figure 7C).
Western blots of the same affinity purifications con-
firmed the enrichment of the NPM1 and CELF1 with
NBL2-monomer derived IVT and not with the control
MALAT1 IVTs (Figure 7D), underscoring the specificity
of these interactions. Some of these factors were not vali-
dated (XRCC5 or PTBP1), while others such as RUVBL2
or PLRG1 also precipitated with MALAT1 IVT. Thus,
from these data, CELF1 and NPM1 were the most specific
and robust interactors of NBL2 IVT. Furthermore, from
UV-crosslinked cell lysates, both CELF1 and NPM1 co-
immunoprecipitated with TNBL compared to negative con-
trols (MALAT1, PUM1 and U1 snRNA). JunD was used
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
TNBL RNA FISH (yellow) confocal imaging in LS174T. SNBs (intense
magenta) are located adjacent to TNBL clusters. White arrows: SNBs that
do not co-localize with TNBL. (B) Left: SAM68 IF and TNBL RNA
FISH STED images, top: both structures in an irregular round form, bot-
tom: elongated form. Scale bar, 5 m. Right: 3D rendering of the bot-
tom left image showing SNB and TNBL aggregate in a lateral interaction
through the entire length of the structures. Scale bar, 1 m. (C) Proximity
calculations between SNB and TNBL cluster in STED imaging (n = 54).
Left: distances between SNB and TNBL clusters centers of mass. Right:
closest exterior distances between SNB and TNBL clusters, median value 0
m and maximum measured distance at 0.42 m. (D) Maximum intensity
projection of TNBL RNA FISH (yellow) and SAM68 IF confocal imaging
in TNBL high expressing LS174T clones. Scale bar, 5 m. (E) SAM68 UV
crosslink RNA IP in high and low TNBL expressing LS174T clones. TNBL
and negative control U1 snRNA were monitored by RT qPCR. Error bars
indicate s.d., n = 3, **P ≤ 0.01, as evaluated by unpaired t-test vs. IgG.
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Figure 7. TNBL interacts with CELF1 and NPM1. (A) Polyacrylamide gel with size-separated proteins from RNA-affinity purification (RNA-AP). RNA-
AP was performed with protein extracts from 3 CRC cell lines (DKO TSA treated cells, Caco-2 and LS174T). Probes: NBL2 monomer in vitro transcript
(IVT) unlabeled (NBL2 U) as a background control, NBL2 monomer IVT biotin-labeled (NBL2 L), 2 biotin-labeled negative control IVTs corresponding
to different regions of MALAT1 of the same size and GC content as NBL2 IVT (C1 and C2). Bands indicated with red arrows were cut and subjected to
mass spectrometry in replicas. Band indicated with a blue arrow was pulled down only with MALAT1 IVT 2. U stands for unlabeled, L for labeled. (B)
Proteins with most peptide count within each band. (C) Functional ontology of proteins enriched with NBL2 RNA-AP. (D) Western blot validation of
proteins pulled down with RNA-AP. NBL2 IVT specifically interacts with NPM1 and CELF1 compared with negative control IVTs. (E) UV crosslink and
RNA IP with antibodies against CELF1 (left) and NPM1 (right) in LS174T TNBL high expressing clone. TNBL enrichment was monitored by RT-qPCR
with two primer sets (1 and 3). Enrichment of JunD, MALAT, PUM1 and U1 snRNA was monitored to control background precipitation. Error bars
indicate s.d., CELF1 RNA IP n = 7, NPM1 RNA IP n = 3. ***P ≤ 0.001, as evaluated by unpaired t-test versus IgG.
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as a positive control to determine the strength of these inter-
actions (62), however in our cellular model JunD does not
seem to bind CELF1 (Figure 7E).
DISCUSSION
The impact of DNA hypomethylation in the generation of
chromosomal abnormalities has been described in mice and
human tumors (7,8,10–13), but exactly how this happens is
unknown. DNA hypomethylation of NBL2 MSR is a recur-
rent event of low to intermediate frequency in many types
of cancer, but understanding its functional output has been
hindered because of incomplete mapping of NBL2 MSRs in
the reference genome (32). Here, we mapped the major loca-
tions of NBL2 MSR to four of five human acrocentric chro-
mosomes. We found that hypomethylation of NBL2 MSR
is tightly associated with its expression into lncRNAs, that
we globally designated as TNBL.
Internal promoters of NBL2 MSRs are likely to drive expres-
sion of TNBL in cancer
Based on our results we propose a model where NBL2 loci
are tightly repressed by a synergy between DNA methyla-
tion and histone deacetylation, with DNA methylation be-
ing the sealing repressive mark. In normal colon epithe-
lia, high DNA methylation maintains NBL2 from acrocen-
tric chromosomes 13, 14, 15 and 21 repressed (Figure 8).
This model also includes our previous work (38), where
we showed that in normal colon cells highly methylated
NBL2 loci are also enriched in the repressive histone mark
H3K9me3, whereas upon NBL2 hypomethylation in can-
cer, H3K9me3 is reduced. The present study shows that
in these circumstances, TNBL expression is induced al-
beit at lower levels, and only when acetylated histones are
present at hypomethylated NBL2, TNBL accumulates in
high quantity. Taken into consideration the co-dependency
between DNA methylation and H3K9me3 (63) we cannot
rule out that loss of H3K9me3 could also contribute to
de-repression of NBL2 loci. Thus, TNBL levels originat-
ing from hypomethylated NBL2 may vary between differ-
ent cells, and depend on NBL2 DNA hypomethylation,
H3K9 methylation and histone acetylation degrees, and the
chromosome affected. RT qPCR and Northern blot (Fig-
ure 4E and F, respectively) on somatic cell hybrids indi-
cate that chromosomes 21 (followed by chromosome 15) are
the ones producing higher amounts of TNBL. Given that
DNA/RNA FISH data shows that TNBL aggregates co-
localize with a subset of NBL2 loci (Figure 5D), we reason
that one or both NBL2 MSR alleles of chromosome 21 or
15 originate TNBL aggregates.
Previous work detected NBL2 RNAs in B cell lines from
ICF syndrome patients and two neuroblastoma cell lines
(64). However, due to the lack of a detectable promoter,
NBL2 transcripts were disregarded and considered as run-
throughs from unknown nearby promoters (51). Our results
rule out a run-through transcript, since NBL2 repeats are
consistently transcribed into long transcripts of a defined
length, and we provide evidence that NBL2 MSR promote
their own transcription by harboring internal promoter ac-
tivity, an aspect of MSRs reported before (reviewed in (32)).
We considered a group of transposon elements (TE), lo-
cated adjacent to NBL2 repeats and upstream of TNBL
transcriptional direction, as the initial suspects for promot-
ing TNBL expression, since they share features of putative
promoters for some lncRNAs (65). However, these TEs did
not elicit promoter activity in luciferase assays. Still, we can-
not rule out that these TEs may act as enhancers modulat-
ing NBL2 transcription in vivo. In silico analysis revealed
that monomer repeats contain more than 30 consensus se-
quences for transcriptional factors, but their functional im-
plication is under investigation.
Four acrocentric chromosomes contain NBL2 MSRs in
higher copy numbers and share their proximal DNA se-
quences. NBL2 polymorphisms and copy number variation
between those chromosomes could be the determining fac-
tor in NBL2 promoter activity and consequently TNBL
transcriptional upregulation. Yet, the size of TNBL orig-
inating from different chromosomes appears the same or
very similar, indicating that the transcriptional unit is con-
served in all four acrocentric chromosomes and may not
strictly depend on NBL2 repeat copy number. Northern
blots consistently showed two high molecular weight bands
that could be the result of a splicing or processing event,
or the presence of two different transcriptional start sites
in different monomers. In either case, both transcripts con-
tain at least one repeat unit. Moreover, the fact that endoge-
nous (in LS174T) and drug-induced (AZA and AZA/TSA
treated Caco-2, HCT116, TOV112D and DKO TSA cells)
TNBL transcripts show similar profiles in Northern blot as-
says, reinforces the structured and not random nature of
this transcript. Long read RNA sequencing may eventually
characterize precisely the sequence of TNBL transcripts.
TNBL expression appears to be an aberrant characteris-
tic of cancer cells. However, we cannot exclude the possibil-
ity that NBL2 and NBL2-like sequences may be expressed
in a limited time window during normal development or in
response to physiological signals. In support of this, blast
searches against databases of expressed sequence tags (EST)
in normal tissues such as thymus and pregnant uterus, and
also in teratoma cultures undergoing neuronal differentia-
tion, returned hits of the 1.4 kb NBL2 monomer with high
similarity. We could not determine the transcriptional start
site based on these blast analyses, and 5′ and 3′ RACE ex-
periments failed despite being attempted on several occa-
sions with various approaches, possibly due to the repetitive
nature of this RNA.
TNBL forms part of a cancer-specific perinucleolar body
TNBL aggregates are in close proximity to SAM68 nucleo-
lar bodies (SNB), and our measurements assessing the type
of interaction indicate that a linker molecule may exist be-
tween both structures. In light of DNA/RNA FISH data,
showing that TNBL aggregates co-localize with NBL2 loci,
we wonder whether the nm-scale space between TNBL ag-
gregate and SNB would be sufficient to include chromatin
fibers that in the interphase nucleus are 10 nm thick (66).
SAM68 bodies only appear in tumor cells and depend on
transcription (58). Although not all SNBs were associated
with high quantity of TNBL, the TNBL-SAM68 aggregate
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Figure 8. Model for TNBL expression in CRC. Acrocentric chromosomes 13, 14, 15 and 21 contain tandem arrays of NBL2 MSR, repressed by DNA
methylation and histone deacetylation in normal colon epithelia. Upon NBL2 DNA hypomethylation TNBL lncRNA is expressed at moderate levels. Sub-
sequent increase of histone acetylation results in high TNBL expression. TNBL location is nuclear where it mostly forms aggregates in the perinucleolar
region close to NBL2 loci. These aggregates interact with SNB creating cancer-specific perinucleolar structures. Outside of the perinucleolar aggregates,
TNBL is widely dispersed in the nucleus. Whether TNBL selective binding to NPM1, SAM68 and CELF1 proteins, which are involved in genome organi-
zation, splicing regulation and mRNA stability respectively, could impair their functionalities and potentially impact nuclear architecture and cell behavior
is at the moment unknown.
structure represents a novel and distinct type of cancer-
specific perinucleolar structure.
The perinucleolar compartment can be considered as
a sort of ‘heterochromatin factory’, that contains mainly
silent rDNA clusters and satellite repeats from the short
arm of acrocentric chromosomes (67–69). NBL2 MSR lo-
cation in the short arms of four acrocentric chromosomes,
coincident and relatively close to the location of rDNA
clusters, uni and tri-dimensionally, raises the question of
whether NBL2 MSR is structurally or functionally related
to rDNA. However, our data also shows distinctive features
between NBL2–rDNA and TNBL–rRNA, and thus the two
seem to be only coincidentally related.
TNBL interacts with the RNA processing machinery
The high amount of TNBL transcripts may act as molec-
ular sponges for splicing factors, other RNA species, or
merely distort nuclear organization. In addition to highly
dense TNBL aggregates in the perinucleolar region, TNBL
transcripts are dispersed in the nucleus where they do
not co-localize with NBL2 loci. This opens the possibil-
ity that TNBL transcripts migrate and interact with chro-
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matin or other nuclear macromolecules, thus acting in trans.
Whether dispersed TNBL signals reflect an active move-
ment of molecules to exhibit their trans-related function or
merely passive diffusion from the aggregate is unknown.
CELF1, a widely distributed cytoplasmic and nuclear
protein with multiple functions vital for proper mRNA
metabolism (70), was one of the main TNBL interactors in
the in vitro pull-down assay (RNA-AP). The CELF1-TNBL
binding is intriguing since CELF1 has also been implicated
in multiple diseases including cancer (71,72). Moreover,
CELF1 forms part of cancer-specific perinucleolar bodies
known as the perinucleolar compartment (60,73,74). How-
ever, in LS174T cells we did not detect formation of CELF1
perinucleolar bodies, neither a significant overlap between
TNBL RNA FISH and CELF1 immunofluorescence sig-
nals, probably due to sensitivity limits of both techniques.
Since TNBL was immunoprecipitated with CELF1 in a ro-
bust manner, we hypothesize that CELF1-TNBL interac-
tion may occur in non-perinucleolar regions where TNBL
is less abundant, but still present (Figure 8).
It seems unlikely that the aberrant expression of TNBL
we observed in some CRC cells could be phenotypically in-
consequential. TNBL could be functionally relevant in can-
cer by sequestering and affecting the function of proteins
and/or nucleic acids, as we suggest in the model of Figure 8.
The transcriptional process itself at NBL2 loci rather than
the RNA molecule, could also passively disrupt nuclear or-
ganization. This has been suggested as a mechanism (Cat’s
cradle model) to explain how lncRNAs may impact nuclear
structure (75). Our work started with the aim to identify
the mechanisms that could explain the historically observed
linkage between DNA demethylation and DNA instability
in cancer. Whether TNBL may be part of this link and con-
tribute to nuclear dysfunction by yet unknown mechanisms
remains to be addressed.
Overall, our data discloses several novel structural fea-
tures of macrosatellites and their lncRNAs with potential
implications in genome stability and CRC pathogenesis.
TNBL high expression, high stability, peculiar distribution
in the nucleus, and binding to a group of RNA regula-
tory proteins, indicates it might have an impact in cancer
cell phenotype. TNBL aberrant expression reflects a cancer-
specific change in the epigenetic landscape occurring in a
subset of colorectal tumors. Our work sets the basis for fu-
ture studies to test whether TNBL expression could be a
biomarker of a subset of CRCs with distinct vulnerabilities
exploitable for therapeutic intervention.
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